Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Synagis 100mg°


Contraindicated
No indication during pregnancy

Contraindicated
No indication in breastfeeding women
Synagis 100mg° :
Type Medicine Withdrawn
Originator Biotech (Synagis 100mg)
Agent Interpharma
Distributor Interpharma
Laboratory AbbVie
Manufacturer Boehringer Ingelheim Pharma GmbH & Co KG
Origin Germany
ATC J06BB16
Revision Date 01/11/2013

Your comment will appear shortly after approval

Synagis 100mg° :

Revision Date : 22/08/2014


Effect Frequency
Anaphylactic reactions Not known
Anaphylactic shock Not known
Apnoea (Apnea) Common
Injection site reaction Common
Pyrexia Very Common
Seizures Uncommon
Skin rash Very Common
Thrombocytopenia (Thrombopenia) Uncommon
Urticaria Uncommon

Different Units By MoH Code

Revision Date : 01/11/2013

Synagis 100mg°  MoH 5700 :
Form Powder for solution for injection
Packaging Bottle
Package Size 1x1ml
Strength 100mg
Storage Condition 2-8°C Do not freeze
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 218341/09
Submission date 01/01/2009
Registration Year 2010
Withdrawn Date 2017


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info